Colgate-Palmolive Company, with a market cap of $72.8 billion, is a global consumer goods company offering oral care, personal care, home care, and pet nutrition products. Despite lagging shares performance, the company reported a 5.8% increase in net sales for fiscal 2025 Q4, reaching $5.23 billion. Analysts project a 4.6% year-over-year EPS increase to $3.86 for FY2026. The stock holds a consensus “Moderate Buy” rating, with a Street-high price target of $96, indicating a potential 6.3% upside from the current price. JPMorgan Chase recently raised the price target to $93 with an “Overweight” rating.

Read more at Barchart: Are Wall Street Analysts Bullish on Colgate-Palmolive Stock?